Avere Therapeutics is a biotechnology company headquartered in Philadelphia, Pennsylvania, focused on developing oral therapies for the treatment of IL-23-driven inflammatory…
Ranked competitors and alternatives for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Avere Therapeutics →Already a subscriber? Sign in
Xcout Intel tracks Avere Therapeutics continuously — this profile deepens as new filings, funding, people and hiring data arrive.